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Nicotine dependence is an addiction to tobacco products and a global public health
concern. Association between the SLC6A4 polymorphisms and nicotine dependence is
controversial. Two variable number tandem repeat (VNTR) domains, termed HTTLPR
and STin2, in the SLC6A4 gene are well characterized transcriptional regulatory
elements. Their polymorphism in the copy number of the repeat correlates with the
particular personality and psychiatric traits. We analyzed nicotine dependence in 1,804
participants from Central Vietnam. The Fagerström Test (FTND) was used to evaluate the
nicotine dependence and PCR was used to determine the SLC6A4 HTTLPR and STin2
VNTRs. The HTTLPR VNTR was associated with difficulties to refrain from smoking in
a prohibiting environment. The STIn2 10/10 genotype was associated with (1) years of
smoking, (2) difficulties to quit the first cigarette, and (3) higher number of cigarettes
smoked per day (CPD). Stratification analysis was used to find the genetic interaction
between these two VNTRs in nicotine dependence as they may synergistically regulate
the SLC6A4 expression. Smokers with the S/S HTTLPR genotypes showed a much
stronger association between STin2 10/10 variant and CPD. This finding is consistent
with the molecular evidence for the functional interaction between HTTLPR and STin2
in cell line models, where STin2 has described as a stronger expressional regulator.
Similarly, we found that STin2 is a much stronger modifier of smoking with 10/10
genotype related to higher nicotine dependence. The present study supports genetic
interaction between HTTLPR and STin2 VNTRs in the regulation of nicotine dependence
with the dominance of the STin2 effects. This finding could be explained by their
differential effect on the SLC6A4 expression.
Keywords: variable number tandem repeat (VNTR), SLC6A4, smoking, nicotine dependence, fagerström test for
nicotine dependence (FTND), vietnam, genetic interaction, stratification
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INTRODUCTION
Smoking is the single major cause for health loss and premature
death (Jha, 2009). Nicotine dependence is a dominant driving
force that prevents successful quitting and causes a craving for
tobacco. Genetic influences on nicotine dependence have been
identified in several candidate gene and GWAS studies (Saccone
et al., 2007; Thorgeirsson et al., 2010; Hancock et al., 2017). The
most dominating associations have been found with nicotinic
cholinergic receptor subunits (Saccone et al., 2009). However,
development of nicotine dependence is complex, and several
other genes involved in the neurotransmission are found to be
associated with this process. One of the functional targets is
serotonin transporter (5HTT, SERT1) also termed solute carrier
family 6 member 4 (SLC6A4). This gene is a target for many
psychostimulants and implicated in many psychiatric conditions
and personality traits (Collier et al., 1996b; Lesch et al., 1996).
Genetic variations in several serotoninergic genes are
associated with different psychiatric illnesses (Battersby et al.,
1996; Collier et al., 1996a,b; Ueno, 2003). Two polymorphic
variable number tandem repeats (VNTRs) in the SLC6A4 gene
are amongst the most commonly analyzed polymorphisms for
psychiatric and personality associations (Lesch et al., 1994; Collier
et al., 1996b).
The most widely analyzed VNTR is in the promoter (termed
5HTT LPR or HTTLPR) consisting of 22–23 bp tandemly
repeated units (Lesch et al., 1994; Heils et al., 1996). Initially the
HTTLPR was identified as a biallelic variation comprising of 14
(short, S) and 16 (long, L) copies of the units (Haddley et al.,
2012). This variation has substantial impact on the expression
of the SLC6A4 with the S allele as low activity and L allele
as the high activity variants (Heils et al., 1997). The functional
SNP (rs25531, A/G) has been identified within the long variant
giving rise to LA or LG variants and many other combinations
between VNTR and A/G polymorphism have been determined
(Nakamura et al., 2000). However, the functional relevance of
LA or LG variants is not sufficiently understood and majority
of studies consider only L or S alleles for the HTTLPR (Martin
et al., 2007; Haddley et al., 2008). The low expressing S allele has
been repeatedly found to be related to depression, bipolar disease,
anxiety and drug addiction (Haddley et al., 2012). A second
functional VNTR resides in the second intron of SLC6A4 gene
and is known as STin2 (Collier et al., 1996b). It consists of 9,
10, or 12 copies of a 16–17 bp tandem sequence termed STin2.9,
STin2.10, and STin2.12 (Haddley et al., 2008). Compared to
the HTTLPR variations, STin2 polymorphisms are studied less
frequently. However, STin2 has a positive impact on the gene
expression and several reports have found its clinical relevance
for disease susceptibility and drug response (Vasiliou et al., 2012;
D’Souza et al., 2013). Of the two VNTRs this one has been tested
functional in transgenic models and shown overlap of function to
the SLC6A4 gene during development (MacKenzie and Quinn,
1999). The most prevalent alleles are 10 and 12 with shorter
allele associated with lower activity of SLC6A4 (Collier et al.,
1996a). STin2.10 has been found to be associated with depression,
neuroticism and suicide (Lopez de Lara et al., 2007; O’Gara et al.,
2008). Taken together, STin2 and HTTLPR are VNTRs regulating
expression of the SLC6A4 (Haddley et al., 2012). Therefore,
variations in the length of the VNTRs are not only a biomarkers
for an association of a behavioral trait but can also differentially
regulate the gene expression providing a mechanism partially
underpinning that association.
Personality traits influence smoking behavior and higher
neuroticism and anxiety has been found in smokers (Patton
et al., 1997). Neuroticism is a personality trait with well-known
heritable component, it correlates with anxiety, mood disorders
and smoking behavior (O’Gara et al., 2008). Higher neuroticism
is associated with more intensive cigarette consumption and less
efficient smoking cessation (O’Gara et al., 2008).
On the other hand, smoking is shown to be involved in suicidal
behavior, but this association has been a controversial for many
years (Doll and Peto, 1976; Davey Smith and Munafo, 2015).
One large prospective study based on 300,000 male United States
Army personnel identified significantly increased relative risk
for suicide among smokers (Miller et al., 2000). The risk of
suicide increased with the number of cigarettes smoked per day
(Miller et al., 2000) and this result has resulted in much debate
of its significance (Sheikh, 2000; Smith and Phillips, 2001). Our
previous study based on the Estonian National Death Registry
data confirmed that smokers have significantly higher incidence
for suicide as cause of death (Koks et al., 2017). Significantly
increased number of suicides is an indication of the increased risk
for mental disorders and self-inflicting behavior among smokers.
As VNTRs in SLC6A4 gene are related to the mood
disorders, suicide risk and smoking-related personality traits,
we wanted to address the association between SLC6A4 and
nicotine dependence. Existing data support that variations in the
SLC6A4 gene are involved in tobacco dependence and smoking
behavior (Watanabe et al., 2011; de Lima et al., 2012; Pizzo de
Castro et al., 2014). The present study aimed to analyse the
association of two regulatory VNTRs in the SLC6A4 gene and
their interaction in the nicotine dependence of Vietnamese men.
Nicotine dependence was measured using the Fagerström test
(FTND) that is based on six questions about different aspects of
the smoking activity and describing physical nicotine dependence
(Fagerstrom, 1978; Heatherton et al., 1991). FTND is widely used
and accepted test for smokers with thorough validation to reflect
the degree of physical dependence (Fagerstrom, 1978; Fagerstrom
and Schneider, 1989). FTND has become a standard and robust
approach to measure nicotine dependence for genetic studies. We
found association between the STin2 polymorphism and several
aspects of nicotine dependence in Asian men including a specific
genotype of HTTLPR and STin2 in the nicotine dependence.
MATERIALS AND METHODS
Study Design and Participants
A community based cross-sectional study was performed in
2015 in Da Nang and Hue, Central Vietnam. Altogether, 1,822
participants consisting of 1,453 smokers and 369 non-smokers
were recruited with balanced age distribution to reduce the effect
of potential confounders. Only data of men were collected due to
the already demonstrated extremely low prevalence of smoking
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in Vietnamese women. All participants were over 18 years of
age. The Ethics Review Committees on Human Research of the
University of Tartu, Da Nang University of Medical Technology
and Pharmacy and Hue University of Medicine and Pharmacy
approved the protocols and informed consent forms used in this
study. All participants signed a written informed consent form
during the completion of the questionnaire.
Smoking Data
We defined smokers as an individual that had smoked for at
least one year. This definition fits with the primary goal of
study to analyse nicotine dependence. Using threshold of one
year would give substantial time for development of nicotine
dependence. This time-based threshold would also filter out
persons who occasionally tried smoking but eventually did not
became dependent. Therefore, the temporal threshold excludes
short-time smokers from the study and only people with some
minimal regular smoking experience were included. The original
questionnaire used in the study contained 19 questions and was
designed to collect demographic information, smoking behavior
and nicotine dependence. The collected data was then inputted
into the web-based database using the RedCap software,1 which
is now available for any other future studies (Harris et al., 2009).
RedCap is an abbreviation for the Research Electronic Data
CAPture and is an innovative software to support clinical and
translational research. RedCap is a workflow methodology for
rapid development and deployment of electronic data capture
which can be used in a clinical setting. Therefore, it is an ideal
platform for subsequent smoking studies.
The following questions were asked during data collection:
1. Year of birth
2. Sex
3. Ethnicity
4. “Have you ever smoked at least one year?”
5. “Are you a current or former smoker?”
6. Age of starting smoking
7. Age of stopping smoking
8. Types of tobacco products
9. The main cause of smoking
10. “How soon after waking up do you smoke your first
tobacco?”
11. “Do you find it difficult to refrain from smoking in places
where it is forbidden?”
12. “Which tobacco would you hate most to give up?”
13. “How many cigarettes per day (CPD) do you smoke?”
14. “Do you smoke more frequently in the morning?”
15. “Do you smoke even if you are sick in bed most of the day?”
16. “Have you ever tried to quit smoking?”
17. “For what reasons have you tried to quit smoking?”
18. “Have you re-started smoking again?”
19. “Why did you re-start smoking again?”
The first questions were used to assess the smoking habits
more generally. Questions 10 to 15 are part of the Fagerström
test for nicotine dependence (FTND). Responses to this section
1https://www.project-redcap.org
were converted to numerical values and a summary score out
of ten was generated. Ten is the maximum value for the FTND
and the scoring was based on the revised version of the test
(Heatherton et al., 1991). The remaining questions described
quitting behavior and reasons for quitting (health, price) and
analyzed different motivators to restart smoking. This design for
the questionnaire meant that it was short, relatively easy to use
and is now imported to the web-based platform for convenient
use via personal computers or mobile devices.
Saliva Collection and DNA Extraction
DNA was collected and extracted from saliva using Norgen saliva
collection, preservation and isolation kit (RU35700)2. Briefly,
2 ml of saliva was collected, mixed with the preservative reagent
and transported to the lab in Tartu, Estonia. DNA was extracted
according to the manufacturers protocol using Proteinase K
digestion and alcohol precipitation.
DNA Genotyping
Assay for genotyping the HTTLPR and STin2 is generally
based on the method described by Wendland et al. (2006)
with slight modifications. Multiplex polymerase chain reaction
(PCR) protocol was used along with two different primer
pairs (Supplementary Table S1) to amplify fragments including
HTTLPR (S – 469bp and L – 512 bp) as well as STin2
VNTR genotypes (9, 10, and 12 repeats). The final reaction
volume (20 ul) contained 1x AmpliTaq Gold MasterMix (Applied
Biosystems, California, CA, United States) and oligonucleotide
primers (TAG Copenhagen A/S) (Supplementary Table S1) at
final concentration of 200 and 350 nM each, respectively. The
final amount of gDNA was 25 ng. Thermal cycling consisted of
4 min of initial denaturation at 95◦C followed by 41 cycles of 95◦C
(20 s), 62◦C (20 s), and 72◦C (20 s) each with a final extension step
of 2 min at 72◦C. Subsequently, 10 ul of PCR product was loaded
onto a 2% agarose gel, run for 1 h and 10 min at 160V in TBE and
visualized by ethidium bromide.
Statistical Analysis
Statistical analysis was performed with R studio by using package
SNPassoc. Package SNPassoc is designed to carry out most
common analyses in association studies (Gonzalez et al., 2007).
The package combines tools to carry out an analysis between
a single SNP and phenotype (quantitative or categorical) under
different genetic models: codominant, dominant, recessive, over-
dominant and log-additive. The statistical significance of a given
SNP is tested using likelihood ratio test, LRT. The standard
output consists of samples size, genotype frequencies, effect sizes
(different measures for quantitative and categorical data), p-value
and the Akaike Information Criterion (AIC) of each genetic
model (Gonzalez et al., 2007).
The phenotypes we involved in the analysis were the smoking
intensity, the years of smoking, FTND and single values of each
FTND question. Smoking behavior was divided into two major
categories: current smokers (1,453 persons) and never smokers
(369 persons). Smoking activity was measured in four categories;
2https://norgenbiotek.com
Frontiers in Pharmacology | www.frontiersin.org 3 December 2018 | Volume 9 | Article 1398
fphar-09-01398 November 29, 2018 Time: 16:25 # 4
Kõks et al. SLC6A4 and Nicotine Dependence in Vietnam
below 10, 11–20, 21–30, and more than 31 CPD. Based on original
answers, Heaviness of Smoking Index (HSI) was also calculated
(Heatherton et al., 1989). This index h has been shown to be
comparable with the FTND (Chabrol et al., 2005). FTND seems
to perform better than HSI in cases of low nicotine dependence
(Perez-Rios et al., 2009).
RESULTS
HTTLPR Polymorphism
HTTLPR genotypes departed from the Hardy-Weinberg
equilibrium, but as it was caused by the loss of heterozygosity
this could indicate natural variabilities in the South-Asian
population (Chen et al., 2017). Smoking status (smoker versus
non-smoker) was not associated with the variations in the
HTTLPR locus (Table 1). FTND score (Figure 1A) and most
of the questions were also not associated with the HTTLPR
variations including the number of quitting attempts and
HSI score. Fagerström test question 2 (F2) “Do you find it
difficult to refrain from smoking in places where it is forbidden”
was statistically significantly associated with the HTTLPR
alleles under dominant genetic model. L allele was dominantly
associated with increased difficulties to refrain smoking when it
is forbidden (Supplementary Table S2). The OR was 1.32 (CI
1.02–1.70) with the p-value of 0.04.
STin2 Polymorphism
The STin2 polymorphism did not depart from the Hardy-
Weinberg equilibrium, but similarly to HTTLPR, was not
associated with smoking status (Table 1). However, the years of
smoking were under dominant (p-value = 0.01) and codominant
(p-value = 0.03) models significantly associated with the STin2
variations with allele 10 being related to the longer smoking
history (Supplementary Table S3). This association had a linear
nature and is illustrated in the Figure 1B. The mean of the years
for smoking was 25.6 years for 12/12, 28.4 years for 10/12 and 30.6
years for 10/10 genotypes (p-value = 0.03). STin2 allele 10/10 also
had a trend to be associated with the summary score of FTND
without reaching statistical significance. Study participants with
genotype 10/10 had an average FTND score of 4.7 whereas
participants with 10/12 or 12/12 had an average FTND score of
4.0 (Figure 1C). STin2 genotypes were significantly associated
with two questions in the FTND. Responses to question 3 "Which
tobacco would you hate most to give up?" were associated with
STin2 genotypes under log-additive model with OR 1.27 (CI
1.03–1.56) and p-value 0.02. Therefore, the persons with 10/10
genotype have difficulties in giving up the morning cigarette, and
they rated morning cigarette as the most precious. This effect
was distinct in the other genotypes as those with 12/12 valued
it the least while persons with 10/12 genotype were intermediate
(Supplementary Table S4 and Figure 1D). Among the persons
with 12/12 genotype, less than half of subjects valued the morning
cigarette over any other. Among the persons with 10/12 and 10/10
genotypes, more than half valued morning cigarette over any
other (OR 1.27, CI 1.00–1.61, p-value 0.05, Figure 1D).
Question number four in FTND is "How many CPD do you
smoke?" and the answer is given in four categories, less than
10, 11–20, 21 to 30, and more than 31 CPD. According to the
original FTND test, these categories were scored from 0 to 3
so that category less than 10 scored 0, 11–20 scored 1, 21–30
got 2 and more than 31 was scored with 3. STin2 genotypes
were significantly associated under dominant and over-dominant
model with the lowest CPD for the heterozygous persons with
the 10/12 genotype (p-value = 0.02, Table 2 and Supplementary
Figure S1). Taken together, while HTTLPR polymorphism had
only modest association, STin2 polymorphism has clear evidence
for the link with the nicotine dependence.
Interaction and Stratification Analysis
HTTLPR and STin2 are two polymorphisms which
demonstrate transcriptional regulatory properties that could act
combinatorially on SLC6A4 expression and genetic association
studies should consider this (Ali et al., 2010). We performed the
association analysis with the interaction term between these two
VNTRs and did not find any significant interactions.
An alternative approach to analysing the two polymorphisms
with well-established molecular interaction is stratification. The
cohort was stratified by the HTTLPR or STin2 genotypes, and
association testing with different genetic models reapplied. In
specific cases, the effects of single-marker association results
became statistically more significant after stratification.
Stratification based on the STin2 genotypes verified the
association between HTTLPR variations and one’s ability to
refrain from smoking when it is prohibited (Table 3). More
precisely, participants with 12/12 genotypes showed significant
associations under dominant (p-value = 0.02) and over-dominant
(p-value = 0.02) genetic models between F2 scores and HTTLPR
genotypes. The odds ratio for not to withstand smoking urge was
1.43 (CI 1.05–1.95) in persons with S/L or L/L genotypes.
When HTTLPR genotypes stratified participants into L/L, S/L,
and S/S groups the STin2 association with CPD became stronger
in subjects with S/S genotypes (Table 4). In smokers with S/S
genotype the STin2 had a significant co-dominant effect with the
p-value 0.006. The difference described in case of STin2 alone
became stronger as the persons with the S/S and 10/12 genotype
have significantly lower CPD compared to the participants with
10/10 or 12/12 genotypes.
DISCUSSION
Our study was designed to analyse the potential genetic
association of the two regulatory VNTRs within the SLC6A4 gene
in nicotine dependence. We collected DNA from 1,435 smokers
and 369 non-smokers and genotyped both VNTRs. The study
population is from Central Vietnam, from Da Nang and Hue
cities. FTND was utilized to provide reliable and comparable
measures for physical nicotine dependence (Fagerstrom, 1978;
Heatherton et al., 1991).
HTTLPR genotypes departed from the Hardy-Weinberg
equilibrium, but this is most likely caused by the population
substructure and not by the genotyping error. Several pieces
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TABLE 1 | Results of the genotyping of two VNTRs in the SL6A4 gene, HTTLPR and STin2.
VNTRs Never-smokers Smokers OR 95% CI X2 P-value Total HWE p-value
HTTLPR SS 235 925 1.00 NA 1160 < 0.001
SL 73 230 1.25 0.92–1.68 2.33 0.14 303
LL 27 91 1.17 0.73–1.82 2.33 0.5 118
S 543 2080 1.00 NA 2623
L 127 412 1.18 0.95–1.47 2.02 0.15 539
STin2 10/10 8 34 1.00 42 0.14
10/12 93 320 1.22 0.57–2.94 1.48 0.61 413
12/12 268 1085 1.03 0.49–2.45 1.48 0.90 1353
10 109 388 1.11 0.89–1.40 0.72 0.40 497
12 629 2490 1.00 NA 3119
Basic statistic, Hardy-Weinberg equilibrium and association analysis with smoking status is indicated.
FIGURE 1 | (A) FTND scores related to the genotypes of HTTLPR. (B) Years of smoking are associated with the genotypes of STin2. (C) Interrelations between
FTND scores and STin2 genotypes. (D) STin2 genotypes are associated with difficulties in giving up the first cigarette a day. ∗p < 0.05; ∗∗p < 0.01.
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of evidence support that reasoning, First, the genotypes of
STin2 were in Hardy-Weinberg equilibrium. Second, a recent
study indicated that in South-Asian populations the departure is
quite common (Chen et al., 2017). Thirdly, the Hardy-Weinberg
departure that is associated with a loss of heterozygosity may be
explained by the natural or biological causes including population
stratification (Chen et al., 2017).
The majority of the study group were smokers, only 20% of
participants were non-smokers. More smokers were collected
because the primary goal was to analyse the genetics of
nicotine dependence and data from non-smokers was only
used for smoking status comparisons. In the present study,
we considered an individual as a smoker if he had smoked
regularly for at least one year (Doll and Hill, 1950). This
definition was introduced by Doll and Hill in their seminal
paper, where they described the connection between smoking
and lung cancer (Doll and Hill, 1950). This definition of a
smoker was used because it was easier to understand for
TABLE 2 | Polymorphisms in the second intron (STin2) of SLC6A4 gene are associated with the F4 question in the Fagerström Test for Nicotine Dependence, “How
many cigarettes per day do you smoke?” Number of cigarettes was divided into four categories (“< 11”, “11–20,” “21–30,” and “> 30”) and transformed into Fagerström
score points, 0, 1, 2, and 3.
Models Genotype n Mean Dif. 95% CI P-value AIC
Codominant 1212 1073 0.74 0.00 NA 0.06 3259
1012 319 0.63 −0.11 −0.21 to −0.02
1010 34 0.79 0.05 −0.21 to 0.31
Dominant 1212 1073 0.74 0.00 NA 0.04 3258
1012-1010 353 0.65 −0.10 −0.19 to −0.00
Recessive 1212-1012 1392 0.72 0.00 NA 0.57 3262
1010 34 0.79 0.08 −0.18 to 0.33
Overdominant 1212-1010 1107 0.74 0.00 0.02 3257
1012 319 0.63 −0.11 −0.21 to −0.02
log-Additive −0.06 −0.14 to 0.01 0.11 3260
TABLE 3 | After stratification for the STin2 genotypes, the association of HTTLPR polymorphism with the F2 question in the Fagerström Test for Nicotine Dependence,
“Do you find it difficult to refrain from smoking in places where it is forbidden?” became more significant.
Models Genotype “No” “Yes” OR 95% CI P-value AIC
Codominant SS 437 283 1.00 NA 0.05 1267
SL 80 79 1.52 1.08 to 2.15
LL 31 24 1.20 0.69 to 2.08
Dominant SS 437 283 1.00 NA 0.02 1265
SL-LL 111 103 1.43 1.05 to 1.95
Recessive SS-SL 517 362 1.00 NA 0.72 1270
LL 31 24 1.11 0.64 to 1.92
Overdominant SS-LL 468 307 1.00 0.02 1265
SL 80 79 1.51 1.07 to 2.12
log-Additive 548 386 1.24 0.99 to 1.55 0.06 1267
Results of persons with the genotype 12/12 are presented.
TABLE 4 | After stratification for the HTTLPR genotypes, the association of STin2 polymorphism with the F4 question in the Fagerström Test for Nicotine Dependence,
“How many cigarettes per day do you smoke?” became more significant. Results from stratum S/S are presented.
Models Genotype n Mean Dif. 95% CI P-value AIC
Codominant 1212 720 0.75 0.00 NA 0.02 2091
1012 182 0.58 −0.17 −0.29 to −4.63e-02
1010 15 0.87 0.12 −0.27 to 5.01e-01
Dominant 1212 720 0.75 0.00 NA 0.02 2091
1012-1010 197 0.60 −0.15 −0.27 to −2.83e-02
Recessive 1212-1012 902 0.72 0.00 NA 0.45 2096
1010 15 0.87 0.15 −0.24 to 5.36e-01
Overdominant 1212-1010 735 0.75 0.00 0.006 2089
1012 182 0.58 −0.17 −0.29 to −4.89e-02
Log-Additive −0.11 −0.21 to −1.96e-05 0.05 2093
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participants and eliminated casual smokers with very little
smoking activity.
Two well-characterized regulatory VNTRs in the SLC6A4
were analyzed to evaluate the variability of the gene in smoking
(Battersby et al., 1996; MacKenzie and Quinn, 1999; Haddley
et al., 2012). Polymorphism in these VNTRs is also correlated
with several psychiatric diseases and personality traits (Battersby
et al., 1996; O’Gara et al., 2008; Mercer et al., 2012). Nicotine
dependence itself is addictive behavior and is the main reason
why quitting of smoking is so difficult. As smoking is related
to many distinct health consequences, reducing smoking in the
population is a significant public health challenge. Smokers die
10 years earlier than non-smokers on average (Koks et al., 2017).
Smoking has been recognized for many years and confirmed
in well characterized reproducible studies as a major cause of
lung cancer and for chronic lung diseases causing premature
mortality (Doll and Hill, 1999; Doll et al., 2004). However, lung
diseases are not the only causes of mortality induced by smoking.
Several reports have identified the association between suicide
and smoking (Doll et al., 1994; Lucas et al., 2013) including dose-
response relationship between cigarettes smoked per day (CPD)
and suicide risk is described in smokers (Lucas et al., 2013).
While the relation between smoking and suicide is a source
of debate, smoking is related to individual personalities and
psychiatric disorders that are linked to suicide or self-inflicting
behavior (Patton et al., 1997; Brody et al., 2005; O’Gara
et al., 2008). Similarly, personality traits and mood disorders
are associated with distinct genetic markers, most commonly
related to serotonergic transmission. SLC6A4 is one of the
most intensively studied targets in psychiatric and psychological
reports. That makes SLC6A4 an exciting candidate for the genetic
association studies on smoking behavior.
Our study aimed to find association between nicotine
dependence and SLC6A4. We focused on well-characterized
VNTRs which have not only been associated with mental
health status but also their ability to act as transcriptional
regulatory domains is recognized. The genotype of HTTLPR and
STin2 is associated with expression of SLC6A4 and high versus
low variants exist (Vasiliou et al., 2012). HTTLPR S allele is
considered to be low expressing variant as is STin2 10 variant.
Moreover, these VNTRs interact with each other in the regulation
of SLC6A4 expression and different haplotypes (L/L 12/12 versus
S/S 10/10) have different effects (Vasiliou et al., 2012; D’Souza
et al., 2013).
Results from present study support the findings from existing
literature and give further evidence for the involvement of
SLC6A4 in nicotine dependence (O’Gara et al., 2008; Chu
et al., 2009). Our present study significantly advances existing
literature on the role of the SLC6A4 in nicotine dependence as
it indicates differential and interactive effect of HTTLPR and
STIn2 in nicotine dependence. With the promoter HTTLPR
alone we did not observe strong associations in any of the
questions addressed apart from under dominant models in which
there was an association between the L allele and the question
F2 (Supplementary Table S2). However, after stratification for
the STin2 genotypes, the association of HTTLPR LL or SL
genotypes with question F2 became stronger in smokers with
the Stin2 12/12 genotypes. Interaction indicates that those with
two combined high activity variants (12 and L) have more
difficulties to refrain from smoking indicating higher nicotine
dependence.
The primary genetic associations were found with the STin2
variants. Specifically the association between dependence and the
low activity genotype (10/10) was found. In all three phenotypes
- years of smoking, “Which tobacco would you hate most to give
up” (F3 question) and "How many CPD do you smoke?" (F4
question), the genetic models were dominant or over-dominant
with main effects from the 10/10 genotypes.
Further, after stratification by the genotypes of HTTLPR,
persons with S/S genotypes exhibited even stronger association
between 10/10 genotype and question F4 under dominant
and over-dominant models. Therefore, low activity VNTR
variants interact at the genetic level increasing the association
with nicotine dependence. The most plausible explanation
is a mechanistic combinatorial action of these regulatory
domains observed in cell line models upon gene expression.
The odds ratios were more pronounced in cases with the
STin2 10/10 variants than in 10/12 and 12/12 variants. This
difference indicates a stronger impact of the STin2 VNTR
in modulating nicotine dependence. Present study advances
our knowledge about the nicotine addiction by describing the
interaction between two functional VNTR loci in SLC6A4
gene in modifying the smoking behavior. This interaction
is evident after stratification indicating the importance of
personalized and stratified approach in the management of
nicotine addiction. Our study also provides an excellent
example that the interactions between different VTNR loci
should be taken into consideration in genetic association
studies.
The main limitation of present study is the lack of correction
for multiple testing. The main reason we decided not to
apply correction is the exploratory nature of the study. The
significant functional interaction between the VNTRs makes
correlation between these two markers very high. This means
that that markers form linked haplotypes and are not inherited
independently. While we also tested different genetic models for
different questions, this approach is quite similar to the model
fitting procedure. We also used stratification to find interaction
between markers. In order to evaluate the model fitting AIC
was used. Authors find that this approach is more flexible for
the analytical situations where markers are highly correlated
and where conservative corrections could destroy the existing
associations. However, we consider the lack of corrections as
a study limitation and the additional independent studies are
needed to confirm this finding.
A final limitation of the study is the lack of cotinine
measurements and the nicotine metabolism data. Nicotine
metabolism has genetic background and is complex biochemical
process. Analysis for the cotinine content would be used as proxy
for the nicotine metabolism and could help to make Fagerström
data more consistent. Genotyping for the nicotine metabolizing
genes would be another option to take into account potential
differences in the nicotine metabolism. Further studies should
work with these limitations.
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CONCLUSION
We have analyzed the involvement of SLC6A4 genetic variations
in nicotine dependence and identified significant associations of
the STin2 variant with specific measures of nicotine dependence.
The STin2 10/10 genotype is associated with smoking persistence
(years of smoking) and difficulties in stopping smoking. This
effect was stronger in those with S/S HTTLPR genotypes
indicating genetic interaction between these two VNTRs in the
nicotine dependence. It could indicate that those with SLC6A4
low activity genotypes (10/10 and S/S) require extra support for
smoking cessation.
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